<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Soncin F</submitter><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>University of California, San Diego</funding><funding>National Institutes of Health</funding><funding>California Institute for Regenerative Medicine</funding><funding>American Society for Reproductive Medicine</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>National Institute of Child Health and Human Development</funding><funding>National Science Foundation</funding><pagination>1303-1317</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9214048</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(6)</volume><pubmed_abstract>Trophoblast stem cells (TSCs) have recently been derived from human embryos and early-first-trimester placenta; however, aside from ethical challenges, the unknown disease potential of these cells limits their scientific utility. We have previously established a bone morphogetic protein 4 (BMP4)-based two-step protocol for differentiation of primed human pluripotent stem cells (hPSCs) into functional trophoblasts; however, those trophoblasts could not be maintained in a self-renewing TSC-like state. Here, we use the first step from this protocol, followed by a switch to newly developed TSC medium, to derive bona fide TSCs. We show that these cells resemble placenta- and naive hPSC-derived TSCs, based on their transcriptome as well as their in vitro and in vivo differentiation potential. We</pubmed_abstract><journal>Stem cell reports</journal><pubmed_title>Derivation of functional trophoblast stem cells from primed human pluripotent stem cells.</pubmed_title><pmcid>PMC9214048</pmcid><funding_grant_id>TG-MCB140074</funding_grant_id><funding_grant_id>T32 GM008806</funding_grant_id><funding_grant_id>K99 HD091452</funding_grant_id><funding_grant_id>UL1 TR001442</funding_grant_id><funding_grant_id>2UL1TR001442-06</funding_grant_id><funding_grant_id>R01 HD089537</funding_grant_id><funding_grant_id>R00 HD091452</funding_grant_id><funding_grant_id>EDUC2-08388</funding_grant_id><funding_grant_id>R01 HD096260</funding_grant_id><funding_grant_id>R01HD-089537</funding_grant_id><funding_grant_id>R01-HD096260</funding_grant_id><funding_grant_id>T32 GM007198</funding_grant_id><funding_grant_id>S10 OD026929</funding_grant_id><funding_grant_id>K99-R00-HD091452</funding_grant_id><funding_grant_id>T32GM8806</funding_grant_id><funding_grant_id>ACI-1548562</funding_grant_id><pubmed_authors>Cheung VC</pubmed_authors><pubmed_authors>Kallol S</pubmed_authors><pubmed_authors>Farah O</pubmed_authors><pubmed_authors>Kittle R</pubmed_authors><pubmed_authors>Jackson MG</pubmed_authors><pubmed_authors>Morey R</pubmed_authors><pubmed_authors>Fisch KM</pubmed_authors><pubmed_authors>Soncin F</pubmed_authors><pubmed_authors>Bui T</pubmed_authors><pubmed_authors>Pizzo D</pubmed_authors><pubmed_authors>Parast MM</pubmed_authors><pubmed_authors>Requena DF</pubmed_authors><pubmed_authors>Meads M</pubmed_authors><pubmed_authors>Horii M</pubmed_authors><pubmed_authors>Chousal J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Derivation of functional trophoblast stem cells from primed human pluripotent stem cells.</name><description>Trophoblast stem cells (TSCs) have recently been derived from human embryos and early-first-trimester placenta; however, aside from ethical challenges, the unknown disease potential of these cells limits their scientific utility. We have previously established a bone morphogetic protein 4 (BMP4)-based two-step protocol for differentiation of primed human pluripotent stem cells (hPSCs) into functional trophoblasts; however, those trophoblasts could not be maintained in a self-renewing TSC-like state. Here, we use the first step from this protocol, followed by a switch to newly developed TSC medium, to derive bona fide TSCs. We show that these cells resemble placenta- and naive hPSC-derived TSCs, based on their transcriptome as well as their in vitro and in vivo differentiation potential. We</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2025-04-04T03:06:18.188Z</modification><creation>2025-02-19T05:06:17.931Z</creation></dates><accession>S-EPMC9214048</accession><cross_references><pubmed>35594858</pubmed><doi>10.1016/j.stemcr.2022.04.013</doi></cross_references></HashMap>